Financial Analysts Consensus 2023 - 2025 Galenica Group

11.01.2024

2022 A

Elimination

2022 A

Number of

Consensus

Highest

Median

Lowest

in million CHF

(as reported)

Mediservice

(continuing)

estimates

2023 E

Change

2023 E

2023 E

2023 E

Net Sales

4'014.3

425.8

3'588.5

7

3'759.4

4.8%

3'771.8

3'767.1

3'713.2

Products & Care

2'029.6

445.9

1'583.7

6

1'668.5

5.4%

1'692.3

1'662.1

1'645.5

Logistics and IT

2'933.3

-

2'933.3

6

3'075.9

4.9%

3'094.1

3'076.0

3'051.8

Corporate & Elimination

-948.6

-20.0

-928.6

6

-987.1

6.3%

-947.4

-982.3

-1'038.0

EBIT adjusted 1)

200.8

10.2

190.6

7

195.7

2.7%

202.3

194.8

190.9

ROS

5.0%

5.3%

5.2%

5.4%

5.2%

5.1%

Products & Care

153.5

10.2

143.3

6

152.0

6.0%

156.0

151.5

149.7

ROS

7.6%

9.0%

9.1%

9.2%

9.1%

9.1%

Logistics and IT

49.2

-

49.2

6

44.7

-9.2%

46.9

44.9

41.4

ROS

1.7%

1.7%

1.5%

1.5%

1.5%

1.4%

Corporate & Elimination

-1.9

-

-1.9

6

-1.8

-7.8%

0.1

-2.1

-3.1

Net profit adjusted 1)

165.7

8.5

157.2

7

159.3

1.3%

167.2

156.9

154.6

Investments in tangible and intangible assets

70.7

0.5

70.2

6

67.8

-3.3%

70.0

70.0

60.3

in % of net sales

1.8%

2.0%

1.8%

1.9%

1.9%

1.6%

Dividend per share (in CHF, paid in the following year)

2.20

2.20

6

2.24

1.6%

2.30

2.23

2.20

1) Excluding the effects of IAS 19 and IFRS 16

Financial Analysts Consensus 2023 - 2025 Galenica Group

11.01.2024

Consensus

Number of

Consensus

Highest

Median

Lowest

in million CHF

2023 E

estimates

2024 E

Change

2024 E

2024 E

2024 E

Net Sales

3'759.4

7

3'911.5

4.0%

3'952.0

3'915.1

3'859.1

Products & Care

1'668.5

6

1'746.4

4.7%

1'796.0

1'731.7

1'723.1

Logistics and IT

3'075.9

6

3'186.5

3.6%

3'210.9

3'184.1

3'154.3

Corporate & Elimination

-987.1

6

-1'016.8

3.0%

-966.3

-1'013.6

-1'078.0

EBIT adjusted 1)

195.7

7

211.5

8.1%

224.8

210.0

204.3

ROS

5.2%

5.4%

5.7%

5.4%

5.3%

Products & Care

152.0

6

161.1

6.0%

170.0

160.2

157.3

ROS

9.1%

9.2%

9.5%

9.3%

9.1%

Logistics and IT

44.7

6

52.0

16.4%

57.7

53.5

43.3

ROS

1.5%

1.6%

1.8%

1.7%

1.4%

Corporate & Elimination

-1.8

6

-1.4

-21.4%

-

-1.6

-2.4

Net profit adjusted 1)

159.3

7

171.6

7.7%

181.0

170.9

163.6

Investments in tangible and intangible assets

67.8

6

68.5

0.9%

70.0

69.8

63.2

in % of net sales

1.8%

1.7%

1.8%

1.8%

1.6%

Dividend per share (in CHF, paid in the following year)

2.24

6

2.32

3.9%

2.45

2.30

2.20

1) Excluding the effects of IAS 19 and IFRS 16

Financial Analysts Consensus 2023 - 2025 Galenica Group

11.01.2024

Consensus

Number of

Consensus

Highest

Median

Lowest

in million CHF

2024 E

estimates

2025 E

Change

2025 E

2025 E

2025 E

Net Sales

3'911.5

7

4'063.6

3.9%

4'133.0

4'071.4

3'999.9

Products & Care

1'746.4

6

1'826.1

4.6%

1'894.0

1'813.4

1'784.8

Logistics and IT

3'186.5

6

3'299.9

3.6%

3'339.3

3'299.0

3'250.7

Corporate & Elimination

-1'016.8

6

-1'051.7

3.4%

-985.6

-1'051.3

-1'119.6

EBIT adjusted 1)

211.5

7

223.3

5.6%

243.1

221.2

214.7

ROS

5.4%

5.5%

5.9%

5.4%

5.4%

Products & Care

161.1

6

170.2

5.6%

182.0

168.2

165.3

ROS

9.2%

9.3%

9.6%

9.3%

9.3%

Logistics and IT

52.0

6

55.4

6.5%

61.0

56.2

46.6

ROS

1.6%

1.7%

1.8%

1.7%

1.4%

Corporate & Elimination

-1.4

6

-1.9

39.8%

0.1

-1.8

-5.5

Net profit adjusted 1)

171.6

7

182.0

6.1%

198.0

182.0

172.4

Investments in tangible and intangible assets

68.5

6

69.3

1.2%

72.2

70.0

66.0

in % of net sales

1.7%

1.7%

1.7%

1.7%

1.6%

Dividend per share (in CHF, paid in the following year)

2.32

6

2.43

4.4%

2.61

2.40

2.20

1) Excluding the effects of IAS 19 and IFRS 16

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Galenica AG published this content on 11 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 March 2024 11:23:23 UTC.